+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Recombinant Cell Culture Supplements Market: Focus on Product Type, Applications, 5 Regional Data, 23 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029

  • ID: 4895475
  • Report
  • December 2019
  • Region: Global
  • 250 Pages
  • BIS Research

FEATURED COMPANIES

  • BBI Solutions
  • Evercyte GmbH
  • HiMedia Laboratories
  • Kingfisher Biotech, Inc.
  • Merck KGaA
  • Shenandoah Biotechnology

Key Questions Answered in this Report:


  • What is the role of media and supplements in cell culture and what are the advantages associated with serum-free media? What is the importance of recombinant proteins in cell culture applications?
  • What are the key trends of the global recombinant cell culture supplements market? How is the market evolving and what is its future scope?
  • What are the major drivers, challenges, and opportunities of the global recombinant cell culture supplements market?
  • What are the key developmental strategies implemented by the key players of the global recombinant cell culture supplements to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
  • What is the regulatory scenario of the global recombinant cell culture supplements market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of recombinant cell culture supplements products?
  • What was the market size of the global recombinant cell culture supplements market in 2018 and what is the market size anticipated to be in 2029? What is the expected growth rate of the global recombinant cell culture supplements market during the period between 2019 and 2029?
  • What are the different recombinant supplement products involved in cell culture? Which product type dominates the market in 2018 and why? Which product type is expected to witness the highest growth rate and to dominate in the market in 2029?
  • What are the different application areas of the global recombinant cell culture supplements market? Which application type dominates the market in 2018 and is expected to dominate in 2029?
  • What was the market value of the leading segments and sub-segments of the global recombinant cell culture supplements market? What are the different macro and micro factors influencing the growth of the market?
  • Which region is expected to contribute the highest sales of the global recombinant cell culture supplements market during the period between 2018 and 2029? Which region and country carries the potential for the significant expansion of key companies for different recombinant cell culture supplement products? What are the leading countries of different regions that contribute significantly toward the growth of the recombinant cell culture supplements market?
  • What are the key players of the global recombinant cell culture supplements market and what is their role in the market?

The recombinant cell culture supplements market analysis projects the market to grow at a significant CAGR of 12.93% during the forecast period, 2019-2029. The recombinant cell culture supplements market generated $258.8 million in revenue in 2018, in terms of value.

The recombinant cell culture supplements market growth has been primarily attributed to the major drivers in this market such as advantages offered by recombinant cell culture supplements and the promising impact displayed by them in culturing cells act as drivers for the growth of the market. Moreover, an increase in funding and investment supporting the advancement of life-science research with an ever-increasing demand for advanced cell culture systems have boosted the adoption rate of recombinant cell-culture supplements products. However, there are significant challenges that are restraining the market growth. These challenges include the shortage of skilled professionals and a lack of proper laboratory infrastructure. Further, the high cost of the cell culturing process and complications involved in it are also acting as a challenge for the market.

Expert Quote

“The most important advantage of utilizing these recombinant proteins is that they facilitate large batch biomanufacturing with minimal risk of contamination and improved adhesion. Another advantage is that it involves animal-free manufacturing which in turn simplifies regulatory issues and export-import issues.”

Scope of the Market Intelligence on Recombinant Cell Culture Supplements Market

The recombinant cell culture supplements market report provides a holistic view of the market in terms of various factors influencing it, including product optimization, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the market. In addition, the study also includes exhaustive information on the unmet needs, perception of the new products, competitive landscape, market share of leading manufacturers, the growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global recombinant cell culture supplements market.

Market Segmentation


  • The recombinant cell culture supplements market segmentation (on the basis of product) is further segmented into recombinant insulin, transferrin, albumin, among others.
  • The recombinant cell culture supplements market segmentation (on the basis of application) is segmented into stem cell and regenerative medicine, bio-production, and academic and research.
  • The recombinant cell culture supplements market segmentation (on the basis of the region) is segmented into North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World.

Key Companies in the Recombinant Cell Culture Supplements Market

The key manufacturers who have been contributing significantly to the Recombinant Cell Culture Supplements Market include Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Hi-Media Laboratories, Sartorius AG, InVitro, SeraCare Life Sciences, Inc., GE Healthcare, Novozymes A/S, and Advanced Biotechnologies, Inc., among others.


Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BBI Solutions
  • Evercyte GmbH
  • HiMedia Laboratories
  • Kingfisher Biotech, Inc.
  • Merck KGaA
  • Shenandoah Biotechnology


Executive Summary
1 Scope of the Work
1.1 Overview: Report Scope
1.2 Segmentation of the Global Recombinant Cell Culture Supplements Market
1.3 Assumptions and Limitations
1.4 Key Questions Answered in the Report
1.5 Base Year and Forecast Period
2 Research Methodology
2.1 Overview: Report Methodology
3 Market Overview
3.1 Fundamentals of Cell Culture
3.2 Role of Media and Supplements
3.3 Serum-free Media vs. Serum containing Media
3.4 Technological Advancements of Defined Media and the Importance of Recombinant Cell Culture Supplements
3.5 Recombinant Cell Culture Supplements Market Scenario
3.6 Assumptions and Limitations for Market Size Calculations
4 Market Dynamics
4.1 Impact Analysis
4.2 Market Drivers
4.2.1 Benefits of Using Recombinant Cell Culture Supplements
4.2.2 Increase in Funding and Investment in R&D of Life Science Sector
4.2.3 Rising Demand for Advanced Cell Culture Products
4.3 Market Restraints
4.3.1 High Cost of Cell Biology Research
4.3.2 Technical Considerations Associated with Cell Culture
4.3.3 Lack of Infrastructure and Skilled Professionals for Cell-based Research
4.4 Market Opportunities
4.4.1 Rising Demand for Monoclonal Antibodies and Stem Cell Research
4.4.2 Increasing Preference for Serum-Free Media
5 Industry Insights
5.1 Regulatory Scenario
5.2 Patent Landscape
6 Competitive Landscape
6.1 Overview
6.2 Key Developments and Strategies
6.2.1 Product Launch and Development
6.2.2 Collaborations, Partnerships, and Joint Ventures
6.2.3 Acquisitions
6.2.4 Business Expansions
6.2.5 Others
6.3 Market Share Analysis
6.4 Growth Share Analysis
7 Global Recombinant Cell Culture Supplements Market (by Products)
7.1 Overview
7.2 Recombinant Albumin (rAlbumin)
7.3 Recombinant Insulin (rInsulin)
7.4 Recombinant Epidermal Growth Factor (rEGF)
7.5 Recombinant Transferrin (rTransferrin)
7.6 Recombinant Trypsin (rTrypsin)
7.7 Recombinant Insulin-like Growth Factor (rIGF)
7.8 Recombinant Stem Cell Factor Protein (rSCF)
7.9 Recombinant Aprotinin (rAprotinin)
7.10 Recombinant Lysozyme (rLysozyme)
7.11 Others
8 Global Recombinant Cell Culture Supplements Market (by Application)
8.1 Overview
8.2 Stem Cell and Regenerative Medicine
8.2.1 Stem Cell Therapy
8.2.2 Cell Therapy
8.2.3 Gene Therapy
8.3 Bioproduction
8.3.1 Monoclonal Antibodies
8.3.2 Recombinant Proteins
8.3.3 Vaccines
8.3.4 Hormones
8.3.5 Other Biological Products
8.4 Academic and Research Application
9 Global Recombinant Cell Culture Supplements Market (by Region)
9.1 Overview
9.2 North America
9.2.1 Overview
9.2.2 U.S.
9.2.3 Canada
9.3 Europe
9.3.1 Overview
9.3.2 Germany
9.3.3 France
9.3.4 U.K.
9.3.5 Italy
9.3.6 Spain
9.3.7 The Netherlands
9.3.8 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 Overview
9.4.2 China
9.4.3 Japan
9.4.4 South Korea
9.4.5 India
9.4.6 Australia
9.4.7 Rest-of-Asia-Pacific
9.5 Latin America
9.5.1 Overview
9.5.2 Brazil
9.5.3 Mexico
9.5.4 Rest-of-Latin America
9.6 Rest-of-the-World
9.6.1 Overview
9.6.2 Russia
9.6.3 Israel
9.6.4 Kingdom of Saudi Arabia (K.S.A.)
9.6.5 Others
10 Company Profiles
10.1 Overview
10.2 BBI Solutions
10.2.1 Company Overview
10.2.2 Role of BBI Solutions in the Global Recombinant Cell Culture Supplements Market
10.2.3 SWOT Analysis
10.3 Corning Incorporated
10.3.1 Company Overview
10.3.2 Role of Corning Incorporated in the Global Recombinant Cell Culture Supplements Market
10.3.3 Financials
10.3.4 SWOT Analysis
10.4 Evercyte GmbH
10.4.1 Company Overview
10.4.2 Role of Evercyte GmbH in the Global Recombinant Cell Culture Supplements Market
10.4.3 SWOT Analysis
10.5 FUJIFILM Irvine Scientific
10.5.1 Company Overview
10.5.2 Role of FUJIFILM Irvine Scientific in the Global Recombinant Cell Culture Supplements Market
10.5.3 SWOT Analysis
10.6 Gemini Bio-Products
10.6.1 Company Overview
10.6.2 Role of Gemini Bio-Products in the Global Recombinant Cell Culture Supplements Market
10.6.3 SWOT Analysis
10.7 HiMedia Laboratories
10.7.1 Company Overview
10.7.2 Role of HiMedia Laboratories in the Global Recombinant Cell Culture Supplements Market
10.7.3 SWOT Analysis
10.8 InVitria
10.8.1 Company Overview
10.8.2 Role of InVitria in the Global Recombinant Cell Culture Supplements Market
10.8.3 SWOT Analysis
10.9 Kingfisher Biotech, Inc.
10.9.1 Company Overview
10.9.2 Role of Kingfisher Biotech, Inc. in the Global Recombinant Cell Culture Supplements Market
10.9.3 SWOT Analysis
10.10   Lonza Group AG
10.10.1 Company Overview
10.10.2 Role of Lonza Group AG in the Global Recombinant Cell Culture Supplements Market
10.10.3 Financials
10.10.4 SWOT Analysis
10.11   Merck KGaA
10.11.1 Company Overview
10.11.2 Role of Merck KGaA in the Global Recombinant Cell Culture Supplements Market
10.11.3 Financials
10.11.4 SWOT Analysis
10.12   PeproTech, Inc.
10.12.1 Company Overview
10.12.2 Role of PeproTech, Inc. in the Global Recombinant Cell Culture Supplements Market
10.12.3 SWOT Analysis
10.13   Shenandoah Biotechnology
10.13.1 Company Overview
10.13.2 Role of Shenandoah Biotechnology in the Global Recombinant Cell Culture Supplements Market
10.13.3 SWOT Analysis
10.14   Sino Biological Inc.
10.14.1 Company Overview
10.14.2 Role of Sino Biological Inc. in the Global Recombinant Cell Culture Supplements Market
10.14.3 SWOT Analysis
10.15   STEMCELL Technologies Inc.
10.15.1 Company Overview
10.15.2 Role of STEMCELL Technologies Inc. in the Global Recombinant Cell Culture Supplements Market
10.15.3 SWOT Analysis
10.16   Thermo Fisher Scientific Inc.
10.16.1 Company Overview
10.16.2 Role of Thermo Fisher Scientific Inc. in the Global Recombinant Cell Culture Supplements Market
10.16.3 Financials
10.16.4 SWOT Analysis
List of Tables
Table 3.1: Recombinant Cell-Culture Supplements Product Offerings of Some Key Companies
Table 4.1: Impact Analysis of Market Dynamics
Table 5.1: Global Regulatory Scenario
Table 5.2: Patents Granted between January 2015 and October 2019
Table 7.1: Recombinant Albumin Products
Table 7.2: Global Recombinant Albumin Market (by Applications), 2018-2029
Table 7.3: Global Recombinant Albumin Market (by Stem Cells and Regenerative Medicine), 2018-2029
Table 7.4: Global Recombinant Albumin Market (by Bioproduction), 2018-2029
Table 7.5: Global Recombinant Insulin Market (by Applications), 2018-2029
Table 7.6: Global Recombinant Insulin Market (by Stem Cells and Regenerative Medicine), 2018-2029
Table 7.7: Global Recombinant Insulin Market (by Bioproduction), 2018-2029
Table 7.8: Recombinant EGF Products
Table 7.9: Global Recombinant EGF Market (by Applications), 2018-2029
Table 7.10: Global Recombinant EGF Market (by Stem Cells and Regenerative Medicine), 2018-2029
Table 7.11: Global Recombinant EGF Market (by Bioproduction), 2018-2029
Table 7.12: Recombinant Transferrin Products
Table 7.13: Global Recombinant Transferrin Market (by Applications), 2018-2029
Table 7.14: Global Recombinant Transferrin Market (by Stem Cells and Regenerative Medicine), 2018-2029
Table 7.15: Global Recombinant Transferrin Market (by Bioproduction), 2018-2029
Table 7.16: Recombinant Trypsin Products
Table 7.17: Global Recombinant Trypsin Market (by Application), 2018-2029
Table 7.18: Global Recombinant Trypsin Market (by Stem Cells and Regenerative Medicine), 2018-2029
Table 7.19: Global Recombinant Trypsin Market (by Bioproduction), 2018-2029
Table 7.20: Recombinant Trypsin Products
Table 7.21: Global Recombinant rIGF-I Market (by Application), 2018-2029
Table 7.22: Global Recombinant rIGF-I Market (by Stem Cells and Regenerative Medicine), 2018-2029
Table 7.23: Global Recombinant rIGF-I Market (by Bioproduction), 2018-2029
Table 7.24: Recombinant Trypsin Products
Table 7.25: Global Recombinant rSCF Market (by Application), 2018-2029
Table 7.26: Global Recombinant rSCF Market (by Stem Cells and Regenerative Medicine), 2018-2029
Table 7.27: Global Recombinant rSCF Market (by Bioproduction), 2018-2029
Table 7.28: Recombinant Aprotinin Products
Table 7.29: Global Recombinant Aprotinin Market (by Application), 2018-2029
Table 7.30: Global Recombinant Aprotinin Market (by Stem Cells and Regenerative Medicine), 2018-2029
Table 7.31: Global Recombinant Aprotinin Market (by Bioproduction), 2018-2029
Table 7.32: Recombinant Lysozyme Products
Table 7.33: Global Recombinant Lysozyme Market (by Application), 2018-2029
Table 7.34: Global Recombinant Lysozyme Market (by Stem Cells and Regenerative Medicine), 2018-2029
Table 7.35: Global Recombinant Lysozyme Market (by Bioproduction), 2018-2029
Table 7.36: Recombinant Other Supplement Products
Table 7.37: Global Recombinant Other Supplements Market (by Application),  2018-2029
Table 7.38: Global Recombinant Other Supplements Market (by Stem Cells and Regenerative Medicine), 2018-2029
Table 7.39: Global Recombinant Other Supplements Market (by Bioproduction), 2018-2029
Table 8.1: Companies along with Biomanufacturing Facility
Table 8.2: Rank 1. Vacaville Bio-Manufacturing Facility
Table 8.3: Rank 2. Amgen Juncos Bio-Manufacturing Facility
Table 8.4: Rank 3. West Greenwich Bio-Manufacturing Plant
Table 8.5: Rank 4. Portsmouth Bio-Manufacturing Plant
Table 8.6: Rank 5. Biberach Bio-Manufacturing Facility
Table 8.7: Rank 6. Longmont & Lake Centre Bio-Manufacturing Facility
Table 8.8: Rank 7. South San Francisco Bio-Manufacturing Facility
Table 8.9: Rank 8. Penzberg Bio-Manufacturing Facility
Table 8.10: Rank 9. PR05 Biotechnology Plant
Table 8.11: Rank 10. Devens Bio-Manufacturing Plant
Table 9.1: North America: Recombinant Cell Culture Supplements Market (by Product), 2019 vs 2029
Table 9.2: Europe Recombinant Cell Culture Supplements Market (by Product), 2018-2029
Table 9.3: Asia-Pacific Recombinant Cell Culture Supplements Market (by Product), 2018-2029
Table 9.4: Latin America Recombinant Cell Culture Supplements Market (by Product), 2018-2029
Table 9.5: Rest-of-the-World Recombinant Cell Culture Supplements Market (by Product), 2018-2029
List of Figures
Figure 1: Global Recombinant Cell Culture Supplements Market, 2018-2029
Figure 2: Global Recombinant Cell Culture Supplements Market (by Product), 2018 and 2029
Figure 3: Global Recombinant Cell Culture Supplements Market (by Application), 2018 and 2029
Figure 4: Global Recombinant Cell Culture Supplements Market (by Region), 2018 and 2029
Figure 1.1: Global Recombinant Cell Culture Supplements Market Segmentation
Figure 2.1: Global Recombinant Cell Culture Supplements Market Research Methodology
Figure 2.2: Primary Research
Figure 2.3: Secondary Research
Figure 2.4: Data Triangulation
Figure 2.5: Bottom-up Approach (Segment-wise Analysis)
Figure 2.6: Top-Down Approach (Segment-wise Analysis)
Figure 2.7: Considered Factors for Data Prediction and Modelling
Figure 2.8: Assumptions and Limitations
Figure 3.1: Important Terminology
Figure 3.2: Global Recombinant Cell Culture Supplements Market, 2018-2029
Figure 3.3: Recombinant Cell Culture Supplements Market Segmentation
Figure 6.1: Competitive Landscape (January 2015-October 2019)
Figure 6.2: Share of Key Developments and Strategies, January 2015-October 2019
Figure 6.3: Product Launches and Developments (by Company January 2015 and October 2019
Figure 6.4: Collaborations, Partnerships, and Joint Ventures (by Company), January 2015 and October 2019
Figure 6.5: Acquisitions (by Company), January 2015 and October 2019
Figure 6.6: Business Expansions (by Company), January 2015 and October 2019
Figure 6.7: Market Share Analysis of Global Recombinant Cell Culture Supplements Market, 2018
Figure 6.8: Growth-Share Matrix of Global Recombinant Cell Culture Supplements Market, 2018
Figure 7.1: Global Recombinant Cell Culture Supplements Market Segmentation (by Products)
Figure 7.2: Global Recombinant Cell Culture Supplements Market (by Product), 2019 vs 2029
Figure 7.3: Global Recombinant Albumin Market, 2018-2029
Figure 7.4: Global Recombinant Insulin Market, 2018-2029
Figure 7.5: Global Recombinant EGF Market, 2018-2029
Figure 7.6: Global Recombinant Transferrin Market, 2018-2029
Figure 7.7: Global Recombinant Trypsin Market, 2018-2029
Figure 7.8: Global Recombinant IGI-1 Market, 2018-2029
Figure 7.9: Global Recombinant Trypsin Market, 2018-2029
Figure 7.10: Global Recombinant Aprotinin Market, 2018-2029
Figure 7.11: Global Recombinant Lysozyme Market, 2018-2029
Figure 7.12: Global Recombinant Other Supplements Market, 2018-2029
Figure 8.1: Global Recombinant Cell Culture Supplements (by Application)
Figure 8.2: Global Recombinant Cell Culture Supplements Market (by Application), 2019 vs 2029
Figure 8.3: Regenerative Medicine: Present and Future
Figure 8.4: Global Recombinant Cell Culture Supplements Market (by Stem Cell and Regenerative Medicine), 2018-2029
Figure 8.5: Global Recombinant Cell Culture Supplements Market (by Stem Cell and Regenerative Medicine Application), 2019 vs 2029
Figure 8.6: Types of Stem cells
Figure 8.7: Global Recombinant Cell Culture Supplements Market (Stem Cell Therapy), 2018-2029
Figure 8.8: Global Recombinant Cell Culture Supplements Market (Cell Therapy), 2018-2029
Figure 8.9: Global Recombinant Cell Culture Supplements Market (Gene Therapy), 2018-2029
Figure 8.10: Global Recombinant Cell Culture Supplements Market (by Bioproduction), 2018-2029
Figure 8.11: Global Recombinant Cell Culture Supplements (by Bioproduction Application), 2019 vs 2029
Figure 8.12: Global Recombinant Cell Culture Supplements Market (Monoclonal Antibodies), 2018-2029
Figure 8.13: Global Recombinant Cell Culture Supplements Market (Recombinant Proteins), 2018-2029
Figure 8.14: Global Recombinant Cell Culture Supplements Market (Vaccines), 2018-2029
Figure 8.15: Global Recombinant Cell Culture Supplements Market (Hormones), 2018-2029
Figure 8.16: Global Recombinant Cell Culture Supplements Market (Other Biological Products), 2018-2029
Figure 8.17: Global Recombinant Cell Culture Supplements Market (by Academic and Research Application), 2018-2029
Figure 9.1: Global Cell Culture Supplements Market (by Region), 2018 vs 2029
Figure 9.2: Recombinant Cell Culture Supplements Market: Global Insights
Figure 9.3: North America: Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.4: North America: Market Dynamics
Figure 9.5: North America: Recombinant Cell Culture Supplements Market (by Country), 2019 vs 2029
Figure 9.6: U.S.: Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.7: Canada: Cell Culture Supplements Market, 2018-2029
Figure 9.8: Europe: Cell Culture Supplements Market, 2018-2029
Figure 9.9: Europe: Market Dynamics
Figure 9.10: Europe: Recombinant Cell Culture Supplements Market (by Country), 2019 vs 2029
Figure 9.11: Germany Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.12: France Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.13: The U.K. Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.14: Italy Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.15: Spain: Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.16: The Netherlands Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.17: Rest-of-Europe Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.18: Asia-Pacific Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.19: APAC: Market Dynamics
Figure 9.20: Asia-Pacific: Recombinant Cell Culture Supplements Market (by Country), 2019 vs 2029
Figure 9.21: China: Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.22: Japan: Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.23: South Korea Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.24: India Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.25: Australia Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.26: Rest-of-Asia-Pacific Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.27: Latin America Cell Culture Supplements Market, 2018-2029
Figure 9.28: Latin America: Market Dynamics
Figure 9.29: Latin America: Recombinant Cell Culture Supplements Market (by Country), 2018-2029
Figure 9.30: Brazil Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.31: Mexico Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.32: Rest-of-Latin America Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.33: Rest-of-the-World: Cell Culture Supplements Market, 2018-2029
Figure 9.34: Rest-of-the-World Recombinant Cell Culture Supplements Market (by Country), 2019 vs 2029
Figure 9.35: Russia Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.36: Israel: Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.37: K.S.A. Recombinant Cell Culture Supplements Market, 2018-2029
Figure 9.38: Others Recombinant Cell Culture Supplements Market, 2018-2029
Figure 10.1: Shares of Key Company Profiles
Figure 10.2: BBI Solutions: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.3: BBI Solutions: SWOT Analysis
Figure 10.4: Corning Incorporated: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.5: Corning Incorporated: Overall Financials, 2016-2018
Figure 10.6: Corning Incorporated: Revenue (by Segment), 2016-2018
Figure 10.7: Corning Incorporated: Revenue (by Region), 2016-2018
Figure 10.8: Corning Incorporated: R&D Expenditure (2016-2018)
Figure 10.9: Corning Incorporated: SWOT Analysis
Figure 10.10: Evercyte GmbH: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.11: Evercyte GmbH: SWOT Analysis
Figure 10.12: FUJIFILM Irvine Scientific: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.13: FUJIFILM Irvine Scientific: SWOT Analysis
Figure 10.14: Gemini Bio-Products: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.15: Gemini Bio-Products: SWOT Analysis
Figure 10.16: HiMedia Laboratories: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.17: HiMedia Laboratories: SWOT Analysis
Figure 10.18: InVitria: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.19: InVitria: SWOT Analysis
Figure 10.20: Kingfisher Biotech, Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.21: Kingfisher Biotech, Inc.: SWOT Analysis
Figure 10.22: Lonza Group AG: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.23: Lonza Group AG: Overall Financials, 2016-2018
Figure 10.24: Lonza Group AG: Revenue (by Segment), 2016-2018
Figure 10.25: Lonza Group AG: Revenue (by Region), 2016-2018
Figure 10.26: Lonza Group AG: R&D Expenditure (2016-2018)
Figure 10.27: Lonza Group AG: SWOT Analysis
Figure 10.28: Merck KGaA: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.29: Merck KGaA: Overall Financials, 2016-2018
Figure 10.30: Merck KGaA: Revenue (by Segment), 2016-2018
Figure 10.31: Merck KGaA: Revenue (by Region), 2016-2018
Figure 10.32: Merck KGaA: R&D Expenditure (2016-2018)
Figure 10.33: Merck KGaA: SWOT Analysis
Figure 10.34: PeproTech, Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.35: PeproTech, Inc.: Recombinant Proteins for Cell Culture under Growth Factor and Cytokines Segment
Figure 10.36: PeproTech, Inc.: SWOT Analysis
Figure 10.37: Shenandoah Biotechnology: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.38: Shenandoah Biotechnology: SWOT Analysis
Figure 10.39: Sino Biological Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.40: Sino Biological Inc.: SWOT Analysis
Figure 10.41: STEMCELL Technologies Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.42: STEMCELL Technologies Inc.: SWOT Analysis
Figure 10.43: Thermo Fisher Scientific Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 10.44: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 10.45: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.46: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
Figure 10.47: Thermo Fisher Scientific Inc.: R&D Expenditure (2016-2018)
Figure 10.48: Thermo Fisher Scientific Inc.: SWOT Analysis
Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • BBI Solutions
  • Evercyte GmbH
  • HiMedia Laboratories
  • Kingfisher Biotech, Inc.
  • Merck KGaA
  • Shenandoah Biotechnology

According to the market intelligence report titled “Global Recombinant Cell Culture Supplements Market - Analysis and Forecast, 2019-2029”, the global recombinant cell culture supplements market was valued at $258.8 million in 2018 and is anticipated to grow over $977.8 million by 2029. The global recombinant cell culture supplements market is expected to grow at CAGR of forecast period 2019-2029, aided primarily by the increased use of cell culture technology for research, production, and stem cell and regenerative medicine therapy.

Culturing of cells under laboratory conditions allows studying both physiology and biochemistry of cells, which further offers research scopes that are difficult to conduct in-vivo. The effects of drugs or other compounds can easily be tested on cultured cells by controlling parameters such as culture medium, culture conditions, population density, and growth rate. Furthermore, it offers huge prospects in the field of genetics and allows investigating the role of different genes. In the field of oncology and virology, it allows the evaluation of toxic and carcinogenic substances on cells and to understand the interaction of various drugs, viruses, and physical or chemical carcinogens. Other potential application areas include vaccine research, stem cell research, development of protein therapeutics, production of genetically engineered proteins such as monoclonal antibodies, insulin, and hormones, among others, gene therapy, and genetic engineering, among others.

Cell culture is a major process in the biotechnological field for the modern-day life sciences. As the use of cell cultures has increased in the current scenario, the market offers great potential for growth and presents a million-dollar opportunity. Prominent players of cell culture media and supplement market include Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Hi-Media Laboratories, Sartorius AG, InVitro, SeraCare Life Sciences, Inc., GE Healthcare, Novozymes A/S, and Advanced Biotechnologies, Inc., among others.

According to Nitish Kumar Singh, Lead Analyst, “North America is the leading contributor in the recombinant cell culture supplements market and contributed approximately 38.0% to the global market value in 2018. This region is anticipated to grow significantly during the forecast period from 2019 to 2029 and continue to dominate the global market in 2029. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. The Europe region also contributed a significant share of 25.5% to the global market.

Research Highlights:

Recombinant Epidermal growth factor is expected to witness a robust CAGR of 16.29% during the forecast period 2019-2029. However, the recombinant albumin market is anticipated to dominate during the forecast period 2019-2029. Merck KGaA is currently the largest shareholder in the global recombinant cell culture supplements market. This market dominance is attributed to the broad range of recombinant cell culture supplements product portfolio that it is offering in this market and the massive demand for the company’s product lines.

This market intelligence report provides a multi-dimensional view of the global recombinant cell culture supplements market in terms of market size and growth potential. This research report aims at answering various aspects of the global recombinant cell culture supplements market with the help of key factors driving the market, restraints that can possibly inhibit the overall growth of the market, and the current growth opportunities that are going to shape the future trajectory of the market expansion.

Furthermore, the competitive landscape and industry insights chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities, such as product launches and approvals, partnerships, collaborations, business expansions, as well as mergers and acquisitions, among others. The research report provides a comprehensive analysis of the product sales, manufacturers, and trend analysis by segment, and growth share analysis by geographical region. Additionally, the report provides a comprehensive attractive analysis and opportunity analysis for the entire recombinant cell culture supplements market for 2018 and 2029.

This report is a meticulous compilation of research on more than 50 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of more than 15 leading companies, market participants, and vendors. The report also comprises 15 detailed company profiles including several key players, such as Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Hi-Media Laboratories, Sartorius AG, InVitro, SeraCare Life Sciences, Inc., GE Healthcare, Novozymes A/S, and Advanced Biotechnologies, Inc., among others.

Key Questions Answered in the Report:


  • What is the role of media and supplements in cell culture and what are the advantages associated with serum-free media? What is the importance of recombinant proteins in cell culture applications?
  • What are the key trends of the global recombinant cell culture supplements market? How is the market evolving and what is its future scope?
  • What are the major drivers, challenges, and opportunities of the global recombinant cell culture supplements market?
  • What are the key developmental strategies implemented by the key players of the global recombinant cell culture supplements to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
  • What is the regulatory scenario of the global recombinant cell culture supplements market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of recombinant cell culture supplements products?
  • What was the market size of the global recombinant cell culture supplements market in 2018 and what is the market size anticipated to be in 2029? What is the expected growth rate of the global recombinant cell culture supplements market during the period between 2019 and 2029?
  • What are the different recombinant supplement products involved in cell culture? Which product type dominates the market in 2018 and why? Which product type is expected to witness the highest growth rate and to dominate in the market in 2029?
  • What are the different application areas of the global recombinant cell culture supplements market? Which application type dominates the market in 2018 and is expected to dominate in 2029?
  • What was the market value of the leading segments and sub-segments of the global recombinant cell culture supplements market? What are the different macro and micro factors influencing the growth of the market?
  • Which region is expected to contribute the highest sales of the global recombinant cell culture supplements market during the period between 2018 and 2029? Which region and country carries the potential for the significant expansion of key companies for different recombinant cell culture supplement products? What are the leading countries of different regions that contribute significantly toward the growth of the recombinant cell culture supplements market?
  • What are the key players of the global recombinant cell culture supplements market and what is their role in the market?
Note: Product cover images may vary from those shown
  • BBI Solutions
  • Corning Incorporated
  • Evercyte GmbH
  • FUJIFILM Irvine Scientific
  • Gemini Bio-Products
  • HiMedia Laboratories
  • InVitria
  • Kingfisher Biotech, Inc.
  • Lonza Group AG
  • Merck KGaA
  • PeproTech, Inc.
  • Shenandoah Biotechnology
  • Sino Biological Inc.
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.

 


Note: Product cover images may vary from those shown